One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1158/0008-5472.can-22-0848
Copy DOI Journal: Cancer research |  Publication Date: Oct 5, 2022 |
 Citations: 14 |  License type: cc-by |
Affiliation: Shanghai Institutes for Biological Sciences, Soochow University, Central South University, Xiangya Hospital Central South University, Shanghai Jiao Tong University, Xinjiang Medical University, Rhode Island Hospital, Brown University, Tsinghua University, Hangzhou Medical College, Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou Medical University, Zhejiang Provincial People's Hospital, Shantou University, Shantou University Medical CollegeLOXL2 loss reprograms the epigenetic landscape to promote uterine cancer initiation and progression and repress the efficacy of anti-PD-1 immunotherapy, indicating that LOXL2 is a tumor suppressor.
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
